Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir for symptomatic mixed cryoglobulinemia (HCV-related)
2014-004134-26Phase 4Active
- Sponsor
- Centro MASVE
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sofosbuvir in hepatitis C virus infection and cryoglobulinaemia, sponsored by Centro MASVE. Primary endpoints: Clinical response of mixed cryoglobulinemia and Safety and tolerability of sofosbuvir + ribavirin. Started Nov 2014; status: active.
02
Drugs
sofosbuvir
03
Conditions
hepatitis C virus infectioncryoglobulinaemia
Beyond the preview
Go deeper on 2014-004134-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004134-26.